reports
Press Release: Sanofi’s Rezurock recommended for EU approval by the CH...
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease Recommendation supported by safety and efficacy results from several clinical studies and real-world evidenceIf approved, Rezurock would offer a new treatment option in the EU for adult patients and in children aged 12 years and older in late line chronic GVHD Paris, January 30, 2026. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a ...
Communiqué de presse : Le CHMP recommande l'approbation du Rezurock de...
Communiqué de presse : Le CHMP recommande l'approbation du Rezurock de Sanofi dans l’UE pour le traitement de la maladie chronique du greffon contre l’hôte Le CHMP recommande l'approbation du Rezurock de Sanofi dans l’UE pour le traitement de la maladie chronique du greffon contre l’hôte La recommandation s’appuie sur les résultats de sécurité et d’efficacité de plusieurs études cliniques et par des données en vie réelleS’il est approuvé, Rezurock permettrait d’offrir une nouvelle option thérapeutique dans l’Union européenne (UE) pour les patients adultes et chez les enfants âgés de 12 ans...
- Ahmed Ben Salem
- Pierre François Merveille
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
RCO REMY COINTREAU SA
ISS ISS A/S
CGM CEGEDIM SA
VRAP VRANKEN-POMMERY MONOPOLE SA
VETO VETOQUINOL SA
ATE ALTEN SA
ALLAN LANSON-BCC
ENI ENI S.P.A.
ELIS ELIS SA
REP REPSOL SA
AOF ATOSS SOFTWARE AG
EMMN EMMI AG
SLIGR SLIGRO FOOD GROUP N.V.
SSO SCATEC ASA
LIGHT SIGNIFY NV
WLN WORLDLINE SA
BRD BRD-GROUPE SOCIETE GENERALE
ALM ALMIRALL SA
BP. BP P.L.C.
MDM MAISONS DU MONDE SA
2CRSI 2CRSI SA
RBO ROCHE BOBOIS INTERNATIONAL SAS
TOM2 TOMTOM NV
WDP WAREHOUSES DE PAUW SCA
ALHRS HYDROGEN REFUELING SOLUTIONS
SHEL SHELL PLC
CAN CANAL+
- Ahmed Ben Salem
- Pierre François Merveille
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
RCO REMY COINTREAU SA
ISS ISS A/S
CGM CEGEDIM SA
VRAP VRANKEN-POMMERY MONOPOLE SA
VETO VETOQUINOL SA
ATE ALTEN SA
ALLAN LANSON-BCC
ENI ENI S.P.A.
ELIS ELIS SA
REP REPSOL SA
AOF ATOSS SOFTWARE AG
EMMN EMMI AG
SLIGR SLIGRO FOOD GROUP N.V.
SSO SCATEC ASA
LIGHT SIGNIFY NV
WLN WORLDLINE SA
BRD BRD-GROUPE SOCIETE GENERALE
ALM ALMIRALL SA
BP. BP P.L.C.
MDM MAISONS DU MONDE SA
2CRSI 2CRSI SA
RBO ROCHE BOBOIS INTERNATIONAL SAS
TOM2 TOMTOM NV
WDP WAREHOUSES DE PAUW SCA
ALHRS HYDROGEN REFUELING SOLUTIONS
SHEL SHELL PLC
CAN CANAL+
- Juan Ros-Padilla
- Stefano Toffano
ENGI ENGIE SA.
SU SCHNEIDER ELECTRIC SE
KNEBV KONE OYJ CLASS B
MC LVMH MOET HENNESSY LOUIS VUITTON SE
ROG ROCHE HOLDING LTD
VOLV B VOLVO AB CLASS B
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
ABB ABB LTD.
GIVN GIVAUDAN SA
SAND SANDVIK AB
RXL REXEL SA
NOKIA NOKIA OYJ
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
ALO ALSTOM SA
SCHP SCHINDLER HOLDING AG PREF
SAN SANOFI
EZJ EASYJET PLC
01913 PRADA S.P.A.
NEM NEMETSCHEK SE
HM B H&M HENNES & MAURITZ AB CLASS B
DOKA DORMAKABA HOLDING AG
LPP LPP S.A.
MOCORP METSO OUTOTEC OYJ
MONC MONCLER SPA
ASSA B ASSA ABLOY AB CLASS B
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
INGA ING GROEP NV
LDO BANCO SANTANDER S.A.
SAP LEONARDO SPA
SIE SAP SE
ASML SIEMENS AG
STM ASML HOLDING NV
VOS STMICROELECTRONICS NV
CAF VOSSLOH AG
KBX CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
SRAIL KNORR-BREMSE AG
ENR STADLER RAIL AG
ERF SIEMENS ENERGY AG
EPI A EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
ZGN EPIROC AB
ATCO A ERMENEGILDO ZEGNA NV
ATLAS COPCO AB
- Stefano Toffano
ENGI ENGIE SA.
SU SCHNEIDER ELECTRIC SE
KNEBV KONE OYJ CLASS B
MC LVMH MOET HENNESSY LOUIS VUITTON SE
ROG ROCHE HOLDING LTD
VOLV B VOLVO AB CLASS B
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
ABB ABB LTD.
GIVN GIVAUDAN SA
SAND SANDVIK AB
RXL REXEL SA
NOKIA NOKIA OYJ
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
ALO ALSTOM SA
SCHP SCHINDLER HOLDING AG PREF
SAN SANOFI
EZJ EASYJET PLC
01913 PRADA S.P.A.
NEM NEMETSCHEK SE
HM B H&M HENNES & MAURITZ AB CLASS B
DOKA DORMAKABA HOLDING AG
LPP LPP S.A.
MOCORP METSO OUTOTEC OYJ
MONC MONCLER SPA
ASSA B ASSA ABLOY AB CLASS B
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
INGA ING GROEP NV
LDO BANCO SANTANDER S.A.
SAP LEONARDO SPA
SIE SAP SE
ASML SIEMENS AG
STM ASML HOLDING NV
VOS STMICROELECTRONICS NV
CAF VOSSLOH AG
KBX CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES S.A.
SRAIL KNORR-BREMSE AG
ENR STADLER RAIL AG
ERF SIEMENS ENERGY AG
EPI A EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
ZGN EPIROC AB
ATCO A ERMENEGILDO ZEGNA NV
ATLAS COPCO AB
- Martial Descoutures
- Martial Descoutures
- Rafael Bonardell
SANOFI: RDOS. 4T’25 (ANÁLISIS BANCO SABADELL)
Rdos. 4T’25 vs 4T’24: Ventas: 11.303 M euros (+7,0% vs +5,7% BS(e) y +5,5% consenso); EBIT: 2.341 M euros (+12,7% vs +11,7% BS(e) y +13,8% consenso). Rdos. 2025 vs 2024: Ventas: 43.626 M euros (+6,2% vs +5,9% BS(e) y +5,8% consenso); EBIT: 12.149 M euros (+7,1% vs +6,9% BS(e) y +7,3% consenso).
- Research Department
INFORME DIARIO 29 ENERO + RDOS. ESPAÑA Y EUROPA 4T’25. PREVIEWS (ANÁLI...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: AEDAS HOMES, NATURGY, NEINOR HOMES. EUROPA: ING, NOKIA, SANOFI, SAP. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. El lujo arrastra a Europa Caídas en las bolsas europeas tras la mala acogida de Rdos de LVMH y antes de la comparecencia de J...
Press release: 2025: strong sales and EPS growth. Continued profitable...
Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026 2025: strong sales and EPS growth.Continued profitable growth expected in 2026 Paris, January 29, 2026 Q4 sales growth of 13.3% at CER1 and business earnings per share (EPS)2 of €1.53 Pharma launches increased sales by 49.4%, reaching €1.1 billion, primarily driven by Ayvakit and ALTUVIIIODupixent sales increased by 32.2% to €4.2 billion, a strong end to the yearVaccines sales decreased by 2.5% to €2.0 billion, with influenza performing better than anticipatedResearch and Development expenses...
Communiqué de presse : 2025 : année de forte croissance du chiffre d’a...
Communiqué de presse : 2025 : année de forte croissance du chiffre d’affaires et du BNPA. Poursuite d’une croissance rentable attendue en 2026 2025 : année de forte croissance du chiffre d’affaires et du BNPA. Poursuite d’une croissance rentable attendue en 2026. Paris, le 29 janvier 2026 Ventes du T4 en progression de 13,3 % à TCC1 et BNPA2 des activités de 1,53 euro Les ventes des nouveaux lancements pharmaceutiques progressent de 49,4 %, atteignant 1,1 milliard d’euros, principalement supportées par Ayvakit et ALTUVIIIOLes ventes de Dupixent progressent de 32,2 %, atteignan...
- Carole Braudeau
Credit Morning 01/27/2026
APCOA: new bond issuance to reduce its interest burden and pay a dividend|Fnac Darty : Conference call feedback regarding the takeover bid|OPmobility to acquire Hyundai Mobis' lighting business|Jeanbrun scheme: a real boost for new home reservations?|Italmatch: New bond issuance and rating upgrade|
- Carole Braudeau
Morning Crédit 27/01/2026
APCOA: new bond issuance to reduce its interest burden and pay a dividend|Fnac Darty : Feedback conference call relative à l’OPA|OPmobility va racheter l’activité d’éclairage de Hyundai Mobis|Dispositif Jeanbrun, véritable coup de pouce pour les réservations de logements neufs ?|Italmatch: New bond issuance and rating upgrade|
- Jan Frederik Slijkerman
- Jeroen van den Broek
- Jesse Norcross
- Nadège Tillier
- Timothy Rahill
- Ahmed Ben Salem
- Emira Sagaama
- Oddo Sustainability Team
- Ahmed Ben Salem
- Emira Sagaama
- Oddo Sustainability Team
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.